Patents by Inventor Glenn Michael LaMuraglia

Glenn Michael LaMuraglia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Significance of dosimetry in photodynamic therapy of injured arteries
    Publication number: 20030212443
    Abstract: Photodynamic therapy (PDT), the light activation of methylene blue or benzoporphyrin derivatives to produce free-radicals, was shown in vivo to inhibit intimal hyperplasia (IH) and restenosis. The present invention provides an effective clinical approach for PDT treatment which modulates the vascular intervention injury healing response.
    Type: Application
    Filed: December 9, 2002
    Publication date: November 13, 2003
    Inventor: Glenn Michael LaMuraglia
  • Significance of dosimetry in photodynamic therapy of injured arteries
    Patent number: 6520981
    Abstract: Photodynamic therapy (PDT), the light activation of methylene blue or benzoporphyrin derivatives to produce free-radicals, was shown in vivo to inhibit intimal hyperplasia (IH) and restenosis. The present invention provides an effective clinical approach for PDT treatment which modulates the vascular intervention injury healing response.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: February 18, 2003
    Assignee: The General Hospital Corporation
    Inventor: Glenn Michael LaMuraglia